Concepedia

Luis Tobalina

LT

14

Publications

499

Citations

13

H-Index

2013

Active since

Affiliations

Universidad de Navarra(Current)

RWTH Aachen University

AstraZeneca (United Kingdom)

Centro de Estudios e Investigaciones Técnicas de Gipuzkoa

Joint Research Centre

Luis Tobalina is an author at Universidad de Navarra specializing in medicine, cell biology, and systems biology.

ORCID

Top concepts

Publications per year

2013–2024

14

Publications

14

Patient-specific Boolean models of signalling networks guide personalised treatments

Arnau Montagud, Jonas Béal, Luis Tobalina et al. · eLife · 2022 · 94 citations · Full text

, , +16

SLFN11 informs on standard of care and novel treatments in a wide range of cancer models

C Winkler, Joshua Armenia, Gemma N. Jones et al. · British Journal of Cancer · 2020 · 68 citations · Full text

An in-silico approach to predict and exploit synthetic lethality in cancer metabolism

Iñigo Apaolaza, Edurne San José‐Eneriz, Luis Tobalina et al. · Nature Communications · 2017 · 62 citations · Full text

The PARP1 selective inhibitor saruparib (AZD5305) elicits potent and durable antitumor activity in patient-derived BRCA1/2-associated cancer models

Andrea Herencia-Ropero, Alba Llop‐Guevara, Anna D. Staniszewska et al. · Genome Medicine · 2024 · 48 citations · Full text

Context-specific metabolic network reconstruction of a naphthalene-degrading bacterial community guided by metaproteomic data

Luis Tobalina, Rafael Bargiela, Jon Pey et al. · Bioinformatics · 2015 · 34 citations · Full text

Rows per page

1–5 of 14